Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Pt 1
|
pubmed:dateCreated |
1994-8-30
|
pubmed:abstractText |
Adenosine transport in cultured human umbilical vein endothelial cells (HUVEC) was characterized and shown to be mediated by a single facilitated diffusion mechanism. Initial rates of adenosine influx at 22 degrees C were saturable [apparent Michaelis constant, 69 +/- 10 microM; maximum velocity (Vmax), 600 +/- 70 pmol.10(6) cells-1.s-1] and inhibited by nitrobenzylthioinosine (NBMPR). Formycin B had an unusually high affinity [inhibitory constant (Ki), 18 +/- 4.3 microM], whereas inosine had a low affinity (Ki, 440 +/- 68 microM) and nucleobases were without effect on adenosine influx. The number of transporters (1.2 x 10(6) sites/cell) was estimated by NBMPR equilibrium binding (apparent dissociation constant, 0.11 +/- 0.01 nM; maximum binding, 2.0 +/- 0.15 pmol/10(6) cells). In addition, we compared these endothelial cells with those obtained from cords from pregnancies complicated by diabetes (HUVEC-D), since embriopathy may occur in these conditions. HUVEC-D exhibited a 2.3-fold reduction in both the Vmax for adenosine influx and the maximum number of NBMPR binding sites (260 +/- 40 pmol.10(6) cells-1.s-1 and 0.86 +/- 0.08 pmol/10(6) cells, respectively). However, the turnover number for each nucleoside transporter in normal and diabetic HUVEC was similar (approximately 300 adenosine molecules/s). Adenosine metabolism at 10 microM in HUVEC-D was modified compared with normal cells. Intracellular phosphorylation (> 90%) was the predominant pathway in normal HUVEC, whereas in HUVEC-D, substantial levels of adenine and adenosine were detected. The present results demonstrate therefore the downregulation of the NBMPR-sensitive nucleoside transporter and changes in adenosine metabolism in HUVEC from diabetic pregnancies.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
267
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
C39-47
|
pubmed:dateRevised |
2009-9-29
|
pubmed:meshHeading |
pubmed-meshheading:8048491-Adenosine,
pubmed-meshheading:8048491-Biological Transport,
pubmed-meshheading:8048491-Cell Division,
pubmed-meshheading:8048491-Cells, Cultured,
pubmed-meshheading:8048491-Endothelium, Vascular,
pubmed-meshheading:8048491-Female,
pubmed-meshheading:8048491-Humans,
pubmed-meshheading:8048491-Pregnancy,
pubmed-meshheading:8048491-Pregnancy in Diabetics,
pubmed-meshheading:8048491-Reference Values,
pubmed-meshheading:8048491-Thioinosine,
pubmed-meshheading:8048491-Time Factors,
pubmed-meshheading:8048491-Umbilical Veins
|
pubmed:year |
1994
|
pubmed:articleTitle |
Adenosine transport in cultured human umbilical vein endothelial cells is reduced in diabetes.
|
pubmed:affiliation |
Department of Physiology and Biophysics, University of Chile, Santiago.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|